Advertisement
UK markets close in 6 hours

  • FTSE 100

    8,107.36
    +28.50 (+0.35%)
     

  • FTSE 250

    19,827.84
    +225.86 (+1.15%)
     

  • AIM

    755.98
    +2.86 (+0.38%)
     

  • GBP/EUR

    1.1656
    -0.0001 (-0.01%)
     

  • GBP/USD

    1.2512
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    51,534.44
    +338.22 (+0.66%)
     

  • CMC Crypto 200

    1,390.55
    -5.98 (-0.43%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.71
    +0.14 (+0.17%)
     

  • GOLD FUTURES

    2,363.20
    +20.70 (+0.88%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,041.10
    +123.82 (+0.69%)
     

  • CAC 40

    8,028.88
    +12.23 (+0.15%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Top Ranked Momentum Stocks to Buy for September 23rd

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 23rd:

Bellicum Pharmaceuticals, Inc. (BLCM): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

Bellicum Pharmaceuticals, Inc. Price and Consensus

Bellicum Pharmaceuticals, Inc. Price and Consensus
Bellicum Pharmaceuticals, Inc. Price and Consensus

Bellicum Pharmaceuticals, Inc. price-consensus-chart | Bellicum Pharmaceuticals, Inc. Quote

Bellicum Pharmaceuticals’ shares gained 14.9% over the last one month more than S&P 500’s rise of 5.1%. The company possesses a Momentum Score of A.

Bellicum Pharmaceuticals, Inc. Price

Bellicum Pharmaceuticals, Inc. Price
Bellicum Pharmaceuticals, Inc. Price

Bellicum Pharmaceuticals, Inc. price | Bellicum Pharmaceuticals, Inc. Quote

ADVERTISEMENT

Cortexyme, Inc. (CRTX): This biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.2% over the last 60 days.

Cortexyme, Inc. Price and Consensus

Cortexyme, Inc. Price and Consensus
Cortexyme, Inc. Price and Consensus

Cortexyme, Inc. price-consensus-chart | Cortexyme, Inc. Quote

Cortexyme’s shares gained 13.5% over the last one month. The company possesses a Momentum Score of A.

Cortexyme, Inc. Price

Cortexyme, Inc. Price
Cortexyme, Inc. Price

Cortexyme, Inc. price | Cortexyme, Inc. Quote

Radiant Logistics, Inc. (RLGT): This transportation services provider has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Radiant Logistics, Inc. Price and Consensus

Radiant Logistics, Inc. Price and Consensus
Radiant Logistics, Inc. Price and Consensus

Radiant Logistics, Inc. price-consensus-chart | Radiant Logistics, Inc. Quote

Radiant Logistics’ shares gained 18.1% over the last one month. The company possesses a Momentum Score of B.

Radiant Logistics, Inc. Price

Radiant Logistics, Inc. Price
Radiant Logistics, Inc. Price

Radiant Logistics, Inc. price | Radiant Logistics, Inc. Quote

Construction Partners, Inc. (ROAD): This road construction company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days.

Construction Partners, Inc. Price and Consensus

Construction Partners, Inc. Price and Consensus
Construction Partners, Inc. Price and Consensus

Construction Partners, Inc. price-consensus-chart | Construction Partners, Inc. Quote

Construction Partners’ shares gained 14.5% over the last one month. The company possesses a Momentum Score of B.

Construction Partners, Inc. Price

Construction Partners, Inc. Price
Construction Partners, Inc. Price

Construction Partners, Inc. price | Construction Partners, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Wall Street’s Next Amazon

Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.

Click for details >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Construction Partners, Inc. (ROAD) : Free Stock Analysis Report
 
Radiant Logistics, Inc. (RLGT) : Free Stock Analysis Report
 
Cortexyme, Inc. (CRTX) : Free Stock Analysis Report
 
Bellicum Pharmaceuticals, Inc. (BLCM) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research